Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00593385 · ClinicalTrials.gov registry record · NA

Atrium iCAST Iliac Stent Pivotal Study

A NA study, sponsored by Atrium Medical Corporation.

Completed
Registry status
NA
Development phase
165
Enrollment target

NCT00593385: Completed NA study, sponsored by Atrium Medical Corporation.

NCT00593385 is a NA study that has completed, run by Atrium Medical Corporation. The registered enrollment target is 165 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00593385, a NA study, has completed, sponsored by Atrium Medical Corporation.

COMPLETED
Registry status
NA
Development phase
165 participants
Enrollment target

Study Summary

Prospective, multicenter, non-randomized, single-arm registry to evaluate the safety and effectiveness of the iCAST Covered Stent System in the treatment of patients with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or external iliac artery.

Primary Outcome

The primary endpoint is a composite endpoint defined as the occurrence of death within 30 days, target site revascularization within 9 months or restenosis (by ultrasound determination) at 9 months.

Interventions

  • DEVICE iCAST covered stent

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2007-10
Est. Completion 2014-05
Phase NA
Atrium Medical Corporation

5 total trials

What the finished NCT00593385 record still lists

NCT00593385 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which iCAST covered stent is the first listed.

NCT00593385 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00593385 about?

NCT00593385 is a clinical study titled "Atrium iCAST Iliac Stent Pivotal Study". Prospective, multicenter, non-randomized, single-arm registry to evaluate the safety and effectiveness of the iCAST Covered Stent System in the treatment of patients with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or externa...

What is the current status of trial NCT00593385?

This trial is currently completed. It is a NA study. The enrollment target is 165 participants. The study started on 2007-10. Estimated completion is 2014-05.

What interventions are being tested in trial NCT00593385?

The interventions under investigation include: iCAST covered stent (DEVICE).

Who is sponsoring clinical trial NCT00593385?

This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00593385's enrollment target sits among peer trials

165 626th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00593385, the US trial registry maintained by the National Library of Medicine. NCT00593385 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.